Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Feb;35(2):427–432. doi: 10.1128/jcm.35.2.427-432.1997

Immunoblot assay for serodiagnosis of Helicobacter pylori infections.

I Nilsson 1, A Ljungh 1, P Aleljung 1, T Wadström 1
PMCID: PMC229594  PMID: 9003610

Abstract

An immunoblot assay for the serological diagnosis of Helicobacter pylori infection was evaluated. Serum samples from patients whose gastric biopsy specimens were known to be positive or negative for H. pylori on culture were used to establish interpretive criteria for the immunoblot assay. A panel of sera from patients with diseases other than H. pylori infection and sera from healthy blood donors were included to validate these criteria. All sera were initially assessed in an enzyme immunoassay (Ge-EIA), based on acid glycine-extracted cell surface proteins of H. pylori NCTC 11637. The same antigen extract was used in the immunoblot assay. In addition, the Ge-EIA and the immunoblot assay were compared with a commercially available EIA (Seradyn, Color Vue Pylori). Bands of 110/120 kDa and/or two of five low-molecular-mass proteins (26, 29, 30, 31, and 33 kDa, in any combination) showed a strong correlation with the H. pylori culture-positive patients (97.5%) compared to the correlation obtained with the EIA results (Ge-EIA, 87.5%; Seradyn EIA, 92.5%), and the antibody responses to these proteins were considered specific reactions. In 37 of 40 serum samples from culture-negative patients and also in sera from patients with other disorders, a moderate antibody reactivity to the medium-size proteins (43 to 66 kDa) was observed, and these were considered not valuable for a specific immunoblot assay. Among sera from culture-positive patients, 39 of 40 serum samples were defined to be immunoblot positive, and from among sera from culture-negative patients, 3 of 40 serum samples were defined to be immunoblot positive. The use of sera from patients with negative cultures for H. pylori as negative controls may decrease the sensitivity due to sampling error and false-negative culture results. Immunoblot assay-positive results were detected among 10% of sera from patients with other diseases, whereas they were detected among 42.5% of sera by the Ge-EIA and 47.5% of sera by the Seradyn-EIA. The higher number of EIA-positive sera in this group reflects a possible cross-reactivity (false-positive EIA result). Of the blood donors, representing asymptomatic but possibly colonized subjects, 24% were immunoblot positive. In conclusion, our data indicate that immunoblotting is more sensitive as well as more specific than EIA. Moreover, it permits detection of antibody responses to specific antigens, e.g., the cytotoxin-associated CagA protein, which may have pathological implications.

Full Text

The Full Text of this article is available as a PDF (329.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen L. P., Espersen F., Souckova A., Sedlackova M., Soucek A. Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies. Clin Diagn Lab Immunol. 1995 Mar;2(2):156–159. doi: 10.1128/cdli.2.2.156-159.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bazillou M., Fendri C., Castel O., Ingrand P., Fauchére J. L. Serum antibody response to the superficial and released components of Helicobacter pylori. Clin Diagn Lab Immunol. 1994 May;1(3):310–317. doi: 10.1128/cdli.1.3.310-317.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bölin I., Lönroth H., Svennerholm A. M. Identification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein. J Clin Microbiol. 1995 Feb;33(2):381–384. doi: 10.1128/jcm.33.2.381-384.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cutler A. F., Havstad S., Ma C. K., Blaser M. J., Perez-Perez G. I., Schubert T. T. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995 Jul;109(1):136–141. doi: 10.1016/0016-5085(95)90278-3. [DOI] [PubMed] [Google Scholar]
  5. Engstrom S. M., Shoop E., Johnson R. C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol. 1995 Feb;33(2):419–427. doi: 10.1128/jcm.33.2.419-427.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feldman R. A., Deeks J. J., Evans S. J. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. Eur J Clin Microbiol Infect Dis. 1995 May;14(5):428–433. doi: 10.1007/BF02114899. [DOI] [PubMed] [Google Scholar]
  7. Guruge J. L., Schalén C., Nilsson I., Ljungh A., Tyszkiewicz T., Wikander M., Wadström T. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis. 1990;22(4):457–465. doi: 10.3109/00365549009027078. [DOI] [PubMed] [Google Scholar]
  8. Hirschl A. M., Pletschette M., Hirschl M. H., Berger J., Stanek G., Rotter M. L. Comparison of different antigen preparations in an evaluation of the immune response to Campylobacter pylori. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):570–575. doi: 10.1007/BF01962618. [DOI] [PubMed] [Google Scholar]
  9. Kaldor J., Tee W., McCarthy P., Watson J., Dwyer B. Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet. 1985 Apr 20;1(8434):921–921. doi: 10.1016/s0140-6736(85)91687-3. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lelwala-Guruge J., Nilsson I., Ljungh A., Wadström T. Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA. Scand J Infect Dis. 1992;24(4):457–465. doi: 10.3109/00365549209052632. [DOI] [PubMed] [Google Scholar]
  12. Logan S. M., Trust T. J. Molecular identification of surface protein antigens of Campylobacter jejuni. Infect Immun. 1983 Nov;42(2):675–682. doi: 10.1128/iai.42.2.675-682.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Luke C. J., Kubiak E., Cockayne A., Elliott T. S., Penn C. W. Identification of flagellar and associated polypeptides of Helicobacter (formerly Campylobacter) pylori. FEMS Microbiol Lett. 1990 Sep 1;59(1-2):225–230. doi: 10.1016/0378-1097(90)90061-t. [DOI] [PubMed] [Google Scholar]
  14. Newell D. G. Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. J Gen Microbiol. 1987 Jan;133(1):163–170. doi: 10.1099/00221287-133-1-163. [DOI] [PubMed] [Google Scholar]
  15. O'Toole P. W., Logan S. M., Kostrzynska M., Wadström T., Trust T. J. Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J Bacteriol. 1991 Jan;173(2):505–513. doi: 10.1128/jb.173.2.505-513.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perez-Perez G. I., Dworkin B. M., Chodos J. E., Blaser M. J. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988 Jul 1;109(1):11–17. doi: 10.7326/0003-4819-109-1-11. [DOI] [PubMed] [Google Scholar]
  17. Rucheton M., Stefas I., Lamaury I., Coste J., Reynes J., Lemaire J. M., Graafland H. Autoanticorps IgG contre un antigène cellulaire p72 croisant avec l'antigène (MLV) p15-gag: présence dans l'infection HIV 1 précoce, dans l'infection HBV et le Gougerot-Sjögren primitif. C R Acad Sci III. 1992;314(12):533–538. [PubMed] [Google Scholar]
  18. Schaber E., Umlauft F., Stöffler G., Aigner F., Paulweber B., Sandhofer F. Indirect immunofluorescence test and enzyme-linked immunosorbent assay for detection of Campylobacter pylori. J Clin Microbiol. 1989 Feb;27(2):327–330. doi: 10.1128/jcm.27.2.327-330.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sobala G. M., Crabtree J. E., Pentith J. A., Rathbone B. J., Shallcross T. M., Wyatt J. I., Dixon M. F., Heatley R. V., Axon A. T. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 1991 Jul 13;338(8759):94–96. doi: 10.1016/0140-6736(91)90085-4. [DOI] [PubMed] [Google Scholar]
  20. Soltesz V., Zeeberg B., Wadström T. Optimal survival of Helicobacter pylori under various transport conditions. J Clin Microbiol. 1992 Jun;30(6):1453–1456. doi: 10.1128/jcm.30.6.1453-1456.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Telford J. L., Ghiara P., Dell'Orco M., Comanducci M., Burroni D., Bugnoli M., Tecce M. F., Censini S., Covacci A., Xiang Z. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994 May 1;179(5):1653–1658. doi: 10.1084/jem.179.5.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Turbett G. R., Høj P. B., Horne R., Mee B. J. Purification and characterization of the urease enzymes of Helicobacter species from humans and animals. Infect Immun. 1992 Dec;60(12):5259–5266. doi: 10.1128/iai.60.12.5259-5266.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Xiang Z., Censini S., Bayeli P. F., Telford J. L., Figura N., Rappuoli R., Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995 Jan;63(1):94–98. doi: 10.1128/iai.63.1.94-98.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES